Analysis of Active Ingredient Isopropyl Methylphenol in Medicated Soaps by Reversed Phase Chromatography

Importance of the Topic

The analysis of isopropyl methylphenol (IPMP) in medicated soaps is critical for ensuring product safety and regulatory compliance.
The replacement of banned antibacterial agents like triclosan has driven adoption of IPMP, which requires accurate quantification at low concentrations.
High-throughput, reliable methods support quality control in pharmaceutical, cosmetic, and consumer product industries.

Objectives and Study Overview

This study aimed to develop and validate a rapid reversed-phase liquid chromatography method for quantifying IPMP in medicated soaps.
Key goals included separation of IPMP from common parabens, evaluation of fluorescence and UV-visible detectors, and reduction of analysis time and solvent consumption.

Methodology and Instrumentation

Instruments and materials:

• HPLC systems: Shimadzu Nexera™ lite and Nexera XR™
• Analytical columns: Shim-pack™ GIST C18, 250×4.6 mm, 5 µm and 150×3.0 mm, 2 µm
• Mobile phase: water (A) and acetonitrile (B), 50 % B
• Flow rates: 1.0 mL/min (5 µm), 0.8 mL/min (2 µm)
• Column temperature: 40 °C
• Detectors: fluorescence (RF-20AXS, Ex 305 nm/Em 280 nm) and PDA (SPD-M40 at 278 nm)
• Injection volumes: 10 µL (5 µm column), 4 µL (2 µm column)
• Mixer: MR 180 µL II

Sample preparation involved methanolic extraction of soap, membrane filtration (0.2 µm), and dilution to target concentration.

Main Results and Discussion

Separation performance:

• Baseline resolution >2.0 between IPMP and butyl paraben in reversed-phase mode on both columns

Calibration and linearity:

• Linear response from 0.5 to 10 mg/L (0.025–0.5 % w/w) with r2 ≥ 0.9999 for both detectors

Sensitivity comparison:

• Fluorescence detection provided ~20-fold higher S/N ratio than UV at 2 mg/L IPMP

High-speed analysis:

• Analysis time reduced by ~50 %
• Mobile phase consumption reduced by ~40 %

Repeatability:

• %RSD ≤ 1.0 for retention time and peak area across six injections

Application to real samples:

• IPMP content in four commercial medicated soaps determined at ~0.1 % w/w by both detectors and column formats

Benefits and Practical Applications

Reversed-phase mode simplifies handling and equilibration compared to normal phase.
Dual detection offers high sensitivity (fluorescence) and spectral confirmation (PDA) in one run.
High-speed protocol increases sample throughput and reduces solvent usage, lowering operating costs.

Future Trends and Possibilities

Further miniaturization with sub-2 µm and core-shell particles may enhance resolution and speed.
Integration with mass spectrometry could provide structural confirmation and broader analyte panels.
Automated sample prep and on-line dilution can improve consistency and reduce manual effort.
Green chromatography approaches may explore aqueous buffers and biodegradable solvents.

Conclusion

The optimized reversed-phase HPLC method using Shim-pack GIST C18 columns and dual detection reliably quantifies IPMP at regulatory levels in medicated soaps.
Fluorescence detection delivers superior sensitivity while PDA ensures spectral verification.
High-speed analysis maintains resolution and precision, halving run time and solvent use.
Overall, the approach supports robust quality control and high-throughput laboratories.

Reference

1. European Chemicals Agency, Regulation (EU) No 528/2012, 2015.
2. U.S. Food and Drug Administration, Final Rule on Safety and Effectiveness of Antibacterial Soaps, 2016.
3. Ministry of Health, Labour and Welfare (Japan), Notification Yakuseiyakushin 0930 No. 4 and No. 1, 2016.
4. Pharmaceutical Society of Japan, Methods of Analysis in Health Science, 2015.
5. Ministry of Health, Labour and Welfare (Japan), Notification Yakuseiyakushin 0329 No. 13, 2018.